Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 18, 2025Jurnal Riset Akuntansi dan KeuanganOpen Access

Comparative Analysis of Pharmaceutical Company's Financial Perfomance Before and During Covid-19 Crisis

View Full Paper
Ask AI
Bookmark
Share

Authors

GMGlenys MarvelaSRSari RusmitaGDGita Desyana

Discussion

Loading...

Member takes

Overview

Comparative analysis shows stability in financial performance of pharmaceutical companies during COVID-19 crisis, indicating resilience.

Key Points

  • The COVID-19 crisis did not significantly affect pharmaceutical companies' financial performance.
  • Profitability ratios examined included ROA, ROE, NPM, and GPM to measure performance differences.
  • Comparative quantitative research utilized paired sample t-test and Wilcoxon Signed Ranks Test in the analysis.
  • This analysis highlights the stability of the pharmaceutical sector amid economic downturns.

Cite This Study

Marvela et al. (2025) studied this question.

synapsesocial.com/papers/68f408995de60f8893c6ff01https://doi.org/10.17509/jrak.v13i2.85687
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1COMPARATIVE ANALYSIS OF FINANCIAL PERFORMANCE OF PHARMACEUTICAL COMPANIES DURING AND AFTER THE COVID-19 PANDEMIC2025
  2. 2Analysis of the Impact of the COVID-19 Pandemic on Financial Performance in Various Industrial Sectors in Indonesia2025
  3. 3Comparison Analysis of Financial Performance and Financial Distress before and during the Covid-19 Pandemic2024 · 1 citations
  4. 4THE IMPACT OF THE COVID 19 PANDEMIC ON COMPANY FINANCIAL PERFORMANCE (Case Study of a Food & Beverage Company listed on the IDX)2024
  5. 5Comparative Analysis of Financial Ratio Before and During the Covid-19 Pandemic in Retail Trade Companies in Indonesia Before and During the Covid-19 Pandemic2024